David Meek

David D.
Meek is Chief Executive Officer at Genetix Biotherapeutics, Inc. since 2025.
He is Chief Executive Officer & Director at Stargazer Pharmaceuticals, Inc. He serves as Non-Executive Chairman at uniQure NV since 2021.
He is Chairman at Entasis Therapeutics Holdings, Inc. since 2019 and Chairman at Swedish Orphan Biovitrum AB since 2024.
He is Director at Camping & Education Foundation.
He is Independent Director at Cullinan Therapeutics, Inc. since 2024.
Formerly, Mr. Meek was Chief Executive Officer & Director at Mirati Therapeutics, Inc. from 2021 to 2023.
He was President & Chief Executive Officer at Novartis Pharmaceuticals Canada, Inc. from 2005 to 2012.
He was Chief Executive Officer at Ipsen Manufacturing Ireland Ltd. He was President, Chief Executive Officer & Director at FerGene, Inc. from 2020 to 2021.
He was Chief Executive Officer & Director at Ipsen SA from 2016 to 2020.
He was Chairman at Ipsen Pharma SAS. He was Chairman at Entasis Therapeutics, Inc. from 2019 to 2022.
He was Director at European Federation of Pharmaceutical Industries & Assns from 2016 to 2020.
He was Director at Fusion Pharmaceuticals, Inc. from 2023 to 2024.
He was Director at Pharmaceutical Research & Manufacturers of America from 2016 to 2020.
He was Head-Global Franchise at Novartis International AG from 2005 to 2012.
He was Executive Vice President & President-Oncology at Baxalta, Inc. from 2014 to 2016.
He was Chief Commercial Officer at Endocyte, Inc. from 2012 to 2014.
Education includes undergraduate studies at the University of Cincinnati (Ohio).